John Larocca

Companies

• Y-mAbs Therapeutics, Inc.General counsel Jan 16, 2025 to now¹
• Aerie PharmaceuticalsGeneral counsel Feb 21, 2018 to Nov 21, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• APAerie Pharmaceuticals AERI0 shares³Nov 21, 2022
• YMY-mAbs Therapeutics, Inc.0 shares⁴Sep 16, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 16, 2025Returned to company 21,500 shares of Y-mAbs Therapeutics, Inc.⁴
• Jan 17, 2025Granted 21,500 shares of Y-mAbs Therapeutics, Inc.⁵
• Nov 21, 2022Returned to company 53,585 shares at $15.25 of Aerie Pharmaceuticals³
• Aug 14, 2022Shares withheld for tax 771 shares at $11.57 of Aerie Pharmaceuticals⁶
• Mar 18, 2022Granted 19,015 shares of Aerie Pharmaceuticals⁷
• Feb 19, 2022Shares withheld for tax 1,973 shares at $6.00 of Aerie Pharmaceuticals⁸
• Feb 7, 2022Shares withheld for tax 768 shares at $7.24 of Aerie Pharmaceuticals⁹
• Feb 6, 2022Shares withheld for tax 384 shares at $7.05 of Aerie Pharmaceuticals¹⁰
• Feb 4, 2022Shares withheld for tax 1,206 shares at $7.05 of Aerie Pharmaceuticals¹⁰